Abstract:Staphylococcus aureus is a bacterial pathogen that causes bloodstream infections, pneumonia, and skin abscesses and is the primary pathogen responsible for medical devices associated with biofilm infections, accounting for approximately 70 % of cases. Therefore, the World Health Organization (WHO) has designated this microorganism as a top priority due to its role in causing over 20,000 bacteremia-related deaths in the US each year. The issue of pathogen resistance to antibiotics, mainly by a biofilm, further complicates these infections since biofilms render the bacterial colony impervious to antibiotics. However, many natural and synthetic substances also induce bacterial biofilm formation. Therefore, we investigated whether the most common active pharmaceutical ingredients (APIs) could induce biofilm formation in two clinical isolates of extended-spectrum beta-lactamase Staphylococcus aureus, one of them also methicillin-resistant (A2M) and two medical devices. We detected biofilm inducers, inhibitors, and destabilizers. Microbial strain, medical devices, API structure, and concentration influenced the modulatory effects of biofilm. In all devices tested, including microplates, FR18 duodenal probe, and respiratory probe, the clinic isolate methicillin-resistant S. aureus A2M exhibited lower susceptibility to biofilm formation than S. aureus A1. The anti-inflammatory acetaminophen, the hypocholesterolemic lovastatin, and the diuretic hydrochlorothiazide all induced biofilm. However, verapamil, an antihypertensive, and cetirizine, an antihistamine, inhibited biofilm on S. aureus A2M, while propranolol, another antihypertensive, inhibited biofilm on S. aureus A1. Additionally, diclofenac, an analgesic, and cetirizine destabilized the biofilm, resulting in more free bacteria and possibly making them more susceptible to external agents such as antibiotics. Nonetheless, further epidemiologic analyses and in vivo assays are needed to confirm these findings and to establish a correlation between drug use, the onset of bacterial infections in patients, and the use of medical devices. This work provides information about the probable clinical implications of drugs in patients using medical devices or undergoing surgical procedures. Inhibitory APIs could also be used as drug repurposing or templates to design new, more potent biofilm inhibitors.

Bacterial Biofilm Formation of Staphylococcus Epidermidis and Biomaterial Infection

Bacterial Biofilm Growth on 3D-Printed Materials

Formation and Properties of in Vitro Biofilms of Ica-Negative Staphylococcus Epidermidis Clinical Isolates

Organic Compounds Inhibiting S. Epidermidis Adhesion and Biofilm Formation

The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections

Staphylococcus epidermidis biofilm in inflammatory breast cancer and its treatment strategies

Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices

Bacterial adherence and biofilm formation on medical implants: A review

Factors Affecting Microbial Adhesion to Stainless Steel and Other Materials Used in Medical Devices

The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis

Approaches to combating methicillin-resistant Staphylococcus aureus (MRSA) biofilm infections

Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis.

Biofilm Producing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Humans: Clinical Implications and Management

Characterization of Bacterial Etiologic Agents of Biofilm Formation in Medical Devices in Critical Care Setup

Induction of biofilm in extended-spectrum beta-lactamase Staphylococcus aureus with drugs commonly used in pharmacotherapy

Staphylococcus Aureus Biofilm: Formulation, Regulatory, and Emerging Natural Products-Derived Therapeutics

Staphylococcus aureus Biofilm Infection Compromises Wound Healing by Causing Deficiencies in Granulation Tissue Collagen

Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects

Conversion Of Staphylococcus Epidermidis Strains From Commensal To Invasive By Expression Of The Ica Locus Encoding Production Of Biofilm Exopolysaccharide

Implant infections: adhesion, biofilm formation and immune evasion

Biofilm-producing ability of methicillin-resistant Staphylococcus aureus clinically isolated in China